The Myocardial Infarction (MI) Therapeutics Market is growing at a rapid pace, spurred by the increasing rates of cardiovascular diseases, particularly heart attacks, and the ongoing progress in treatment methods. Myocardial infarction, or heart attack, arises from a blockage in the heart's blood supply, leading to the death or damage of heart tissue. As a major global cause of death, the need...